BAX 855 prophylaxis: Efficacy, safety, and immunogenicity in previously treated pediatric patients from the United States, Europe, and the Asia-Pacific region

被引：0
|
作者：
Stasyshyn, Oleksandra [1 ]
Wynn, Tung [2 ]
Sharkhawy, Marlies [3 ]
Engl, Werner [3 ]
Tangada, Srilatha [4 ]
机构：
[1] NAMS Ukraine, Dept Surg & Clin Transfusiol, SI Inst Blood Pathol & Transfus Med, Lvov, Ukraine
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Shire, Vienna, Austria
[4] Shire, Cambridge, MA USA
来源：
HAEMOPHILIA | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M-P-054 (6
引用
收藏
页码：31 / 31
页数：1
相关论文
共 30 条
  • [21] Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
    Abou Dalle, Iman
    Kantarjian, Hagop
    Burger, Jan
    Estrov, Zeev
    Ohanian, Maro
    Verstovsek, Srdan
    Ravandi, Farhad
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Cortes, Jorge
    CANCER MEDICINE, 2019, 8 (15): : 6559 - 6565
  • [22] Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study
    Wei, Lai
    Jia, Ji Dong
    Wang, Fu Sheng
    Niu, Jun Qi
    Zhao, Xu Min
    Mu, Shengmei
    Liang, Li Wen
    Wang, Zaiqi
    Hwang, Peggy
    Robertson, Michael N.
    Ingravallo, Paul
    Asante-Appiah, Ernest
    Wei, Bo
    Evans, Barbara
    Hanna, George J.
    Talwani, Rohit
    Duan, Zhong Ping
    Zhdanov, Konstantin
    Cheng, Pin-Nan
    Tanwandee, Tawesak
    Van Kinh Nguyen
    Heo, Jeong
    Isakov, Vasily
    George, Jacob
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (01) : 12 - 21
  • [23] Long-term safety and efficacy of N8-GP in previously treated pediatric patients with hemophilia A: Final results from pathfinder5
    Saulyte Trakymiene, Sonata
    Economou, Marina
    Kenet, Gili
    Landorph, Andrea
    Shen, Chunduo
    Kearney, Susan
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 : 15 - 25
  • [24] Safety and Efficacy of Delayed-release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from Asia-Pacific and Other Countries: Interim Analysis of the APEX Extension Study
    Saida, Takahiko
    Yamamura, Takashi
    Kondo, Takayuki
    Yun, Jang
    Li, Jie
    Forsythe, Beverley
    Sheikh, Sarah, I
    Zhu, Bing
    NEUROLOGY, 2017, 88
  • [25] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma (HCC): collective results from the phase III sorafenib HCC assessment randomized protocol (SHARP) and Asia-Pacific (AP) trials
    Llovet, J.
    Cheng, A.
    Qin, S.
    Shan, M.
    Nadel, A.
    Burock, K.
    Forner, A.
    Zou, J.
    Bruix, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 367 - 367
  • [26] Safety and Efficacy of Nonacog Beta Pegol (N9-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously-Treated Patients with Hemophilia B: Results from an Extension Trial
    Young, Guy
    Collins, Peter W.
    Tehranchi, Ramin
    Chuansumrit, Ampaiwan
    Hanabusa, Hideji
    Lentz, Steven R.
    Mahlangu, Johnny N.
    Mauser-Bunschoten, Evelien
    Negrier, Claude
    Oldenburg, Johannes
    Patiroglu, Turkan
    Santagostino, Elena
    Zak, Marek
    Karim, Fara Abdul
    BLOOD, 2014, 124 (21)
  • [27] Efficacy and Safety Results from a Phase 3b, Open-Label, Multicenter, Continuation Study of Rurioctocog Alfa Pegol for Prophylaxis in Previously Treated Patients with Severe Hemophilia A
    Mullins, Eric S.
    Konkle, Barbara A.
    McGuinn, Catherine E.
    Engl, Werner
    Tangada, Srilatha D.
    BLOOD, 2018, 132
  • [28] Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A
    Chowdary, Pratima
    Mullins, Eric S.
    Konkle, Barbara A.
    McGuinn, Catherine
    Park, Young Shil
    Stasyshyn, Oleksandra
    Zulfikar, Bulent
    Engl, Werner
    Tangada, Srilatha
    HAEMOPHILIA, 2020, 26 (04) : E168 - E178
  • [29] First report of safety and efficacy of a glycoPEGylated FVIII (N8-GP) in previously treated pediatric patients with severe hemophilia A-results from the international phase 3 pathfinder™5 trial
    Alamelu, Jayanthi
    Ehrenforth, Silke
    Hanabusa, Hideji
    Karim, Faraizah Abdul
    Kavakli, Kaan
    Khodaie, Melanie
    Stabar, Janice
    Stasyshyn, Oleksandra
    Yee, Donald
    Rageliene, Lina
    HAEMOPHILIA, 2016, 22 : 49 - 50
  • [30] Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study
    Kenet, Gili
    Chambost, Herve
    Male, Christoph
    Halimeh, Susan
    Lambert, Thierry
    Li, Yanyan
    Seifert, Wilfried
    Santagostino, Elena
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (04) : 599 - 606
123